- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
Dong-A Socio Holdings
Market Cap: ₩549.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩83,700.00
7D
0.4%
1Y
-29.9%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩245,000.00
7D
-0.2%
1Y
-29.1%
Dong-A ST
Market Cap: ₩350.4b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,000.00
7D
1.4%
1Y
-24.7%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩132,000.00
7D
-1.0%
1Y
-19.7%
PharmaResearch
Market Cap: ₩3.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩330,500.00
7D
5.3%
1Y
-41.6%
Medy-Tox
Market Cap: ₩473.8b
Operates as a biopharmaceutical company in South Korea.
A086900
₩71,500.00
7D
-6.0%
1Y
-55.6%
Hanmi Pharm
Market Cap: ₩4.9t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩380,000.00
7D
-10.2%
1Y
35.7%
SK Biopharmaceuticals
Market Cap: ₩6.5t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,100.00
7D
-5.8%
1Y
-17.3%
ST PharmLtd
Market Cap: ₩2.6t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩125,900.00
7D
1.1%
1Y
49.2%